Lantern Pharma Inc. - stock earnings
LTRN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -3.2 million USD | ? USD |
| 2023Q2 | -4.7 million USD | ? USD |
| 2023Q1 | -3.4 million USD | ? USD |
| 2022Q4 | -2.9 million USD | ? USD |
| 2022Q3 | -2.4 million USD | ? USD |
| 2022Q2 | -4.6 million USD | ? USD |
| 2022Q1 | -4.2 million USD | ? USD |
| 2021Q4 | -3.5 million USD | ? USD |
| 2021Q3 | -4.1 million USD | ? USD |
| 2021Q2 | -2.3 million USD | ? USD |
| 2021Q1 | -2.5 million USD | ? USD |
| 2020Q4 | -2.9 million USD | ? USD |
| 2020Q3 | -1.7 million USD | ? USD |
| 2020Q2 | -833422 USD | ? USD |
| 2020Q1 | -477276 USD | ? USD |
| 2019Q4 | -675167 USD | ? USD |
| 2019Q3 | -669652 USD | ? USD |
| 2019Q2 | -629393 USD | ? USD |
| 2019Q1 | -453973 USD | ? USD |
LTRN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -15.2 million USD | ? USD |
| 2022 | -14.1 million USD | ? USD |
| 2021 | -12.3 million USD | ? USD |
| 2020 | -5.9 million USD | ? USD |
| 2019 | -2.4 million USD | ? USD |
| 2018 | -1.7 million USD | ? USD |
LTRN
Price: $6.22
52 week price:
Earnings Per Share: -1.47 USD
P/E Ratio: -3.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 2116
Market Capitalization: 74.3 million